Efficacy of Topical Cyclosporin 0.05% in the Treatment of Posterior Blepharitis
Publication: Journal of Ocular Pharmacology & Therapeutics
Volume 22, Issue Number 1
Abstract
We assessed the efficacy of topical cyclosporin 0.05% ophthalmic emulsion versus tobramycin 0.3%/dexamethasone 0.1% in patients with posterior blepharitis. Posterior blepharitis improved significantly from the initial study visit with both cyclosporin treatment and tobramycin/dexamethasone. Cyclosporin provided greater improvements in Schirmer's scores (P < 0.001) and tear break-up time (P =0.018) than tobramycin/dexamethasone after 12 weeks of treatment. Eyelid health also improved in both groups, but the mean improvement in meibomian gland secretion quality was significantly greater with cyclosporin than with tobramycin/dexamethasone (P = 0.015). Moreover, a higher percentage of patients in the cyclosporin treatment group had improvements in symptoms of blurred vision, burning, and itching and more cyclosporin-treated patients experienced resolution of lid telangiectasia. The findings in this prospective study suggest that posterior blepharitis can be more effectively treated with cyclosporin than with tobramycin/dexamethasone. These findings should be further evaluated in large-scale, controlled, clinical trials.
Get full access to this article
View all available purchase options and get full access to this article.
Information & Authors
Information
Published In
Journal of Ocular Pharmacology & Therapeutics
Volume 22 • Issue Number 1 • February 2006
Pages: 47 - 53
PubMed: 16503775
Copyright
Copyright 2006, Mary Ann Liebert, Inc.
History
Published online: 27 February 2006
Published in print: February 2006
Topics
Authors
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.